Skip to main content
Contact +1 (919) 234-1277

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
scFv -h-CH2-CH3(_scFv)_h-CH2-CH3

$238.00

100ug + 238 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

Product name Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
Source CAS 1831098-91-9
Species Chimeric,Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Duvortuxizumab,JNJ-64052781,MGD011,RES192M1.2,CD19, CD3E,anti-CD19, CD3E
Reference PX-TA1432
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype scFv -h-CH2-CH3(_scFv)_h-CH2-CH3
Clonality Monoclonal Antibody
Product name Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
Source CAS 1831098-91-9
Species Chimeric,Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Duvortuxizumab,JNJ-64052781,MGD011,RES192M1.2,CD19, CD3E,anti-CD19, CD3E
Reference PX-TA1432
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype scFv -h-CH2-CH3(_scFv)_h-CH2-CH3
Clonality Monoclonal Antibody

General information on Anti-CD19/CD3E[Homo sapiens] (Duvortuxizumab) Monoclonal Antibody

Duvortuxizumab is investigated for the treatment of Lymphoma.

There are no reviews yet.

Be the first to review “Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products